UniDoc Health Corp (UDOC) AI Stock Analysis

• Market Cap: C$11.66M
• Dividend Yield: N/A
• Average Volume (3M): 67.00K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.36
• Revenue Growth: N/A
• EPS Growth: 48.94%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): >-0.01
• Shares Outstanding: 86,350,090
• 10 Day Avg. Volume: 18,137
• 30 Day Avg. Volume: 67,001
• PEG Ratio: -0.02
• Price to Book (P/B): 28.14
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -2.44
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: C$0.10 ▼(-31.43% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is primarily constrained by very large operating losses, negative equity, and substantial ongoing cash burn relative to a small revenue base. Technicals also lean weak with the price below major moving averages and negative MACD. Valuation is further hindered by losses (negative P/E) and no dividend support.

Positive Factors

Telehealth platform & H3 Health Cubes

UniDoc’s integrated hardware+software telehealth offering targets remote consultations and on-site diagnostics. That product-service combination aligns with durable structural demand for virtual care, supports recurring services and differentiated customer value, and can scale revenue per deployment over time.

Positive gross margin

A ~23% gross margin indicates the business can generate gross profit on sales, implying unit economics that cover direct costs. If revenue scales and operating expenses are controlled, this margin provides a pathway to improving operating leverage and eventual profitability over multiple reporting periods.

Low reported debt

Very low reported debt reduces near-term interest and refinancing pressure and gives management flexibility to pursue growth or capital raises without heavy leverage. For a cash-burning early-stage healthcare tech firm, low debt lowers short-term solvency risk and supports strategic options.

Negative Factors

Severe operating losses

Operating and net losses massively exceed revenues, showing the business is far from breakeven. Such structural deficits erode capital, require repeated financing, and constrain ability to invest in product development and sales infrastructure until a sustained reversal in margins occurs.

High cash burn

Consistently large negative operating and free cash flow versus a very small revenue base creates persistent funding needs. Over multiple quarters this raises financing and dilution risk, limits runway for commercialization efforts, and can force trade-offs between growth and liquidity preservation.

Negative shareholders' equity

Negative equity reflects accumulated losses exceeding invested capital, weakening the balance sheet. This reduces borrowing capacity, complicates strategic partnerships and supplier terms, and increases insolvency risk under stress, constraining long-term financial flexibility.

UniDoc Health Corp Business Overview & Revenue Model

Company Description

UniDoc Health Corp. operates as a virtual health/telemedicine solutions company in Canada. It offers Virtual Health Clinics, a customizable solution that offers safe and secure ways to connect patients in urban, rural, and remote locations with medical care, as well as delivers rapid and real-time diagnostic testing, and supplies therapeutic treatment with continued health monitoring. The company was formerly known as Unicheck Holdings Corp. and changed its name to UniDoc Health Corp. in April 2021. UniDoc Health Corp. was incorporated in 2021 and is based in Vancouver, Canada.

How the Company Makes Money

UniDoc Health Corp generates revenue primarily through subscription fees for its telemedicine platform, which healthcare providers pay to access the company's suite of digital tools and services. Additionally, the company earns income from licensing its technology to clinics and hospitals, as well as through strategic partnerships with healthcare organizations and insurance companies that integrate UniDoc's solutions into their service offerings. These partnerships often include revenue-sharing agreements, further contributing to UniDoc's earnings. The company may also benefit from government grants and funding initiatives aimed at promoting digital health technologies.

UniDoc Health Corp Financial Statement Overview

Summary

Despite positive gross margin (~23%) and improved TTM revenue (~$0.46M), results are dominated by extreme operating and net losses (EBIT margin ~-860%, net margin ~-882%) and heavy cash burn (TTM operating cash flow ~-$4.39M; free cash flow ~-$4.72M). Low debt helps, but negative equity (~-$0.86M) elevates financing risk.

Income Statement

TTM (Trailing-Twelve-Months) revenue improved to ~$0.46M (very high reported growth off a low base), and gross margin is positive at ~23%, indicating some ability to generate gross profit. However, operating losses remain extremely large versus revenue (EBIT margin about -860% and net margin about -882%), with net income at roughly -$4.0M, showing the business model is not close to breakeven. Prior annual periods show minimal/zero revenue and ongoing losses, reinforcing limited scale and weak earnings quality.

Balance Sheet

Reported debt is low (TTM total debt ~$48K and annual ~69K), which reduces near-term balance-sheet strain. The key weakness is capital structure: stockholders’ equity is negative in TTM (about -$0.86M) and was also negative in multiple prior years, which increases financial risk and limits flexibility. Total assets are modest (TTM ~$1.78M), and profitability relative to equity is highly unfavorable given continuing net losses.

Cash Flow

Cash generation is weak: TTM operating cash flow is about -$4.39M and free cash flow about -$4.72M, implying significant cash burn. Free cash flow declined further versus the prior annual period (negative growth), pointing to worsening funding needs. While free cash flow tracks net loss closely (free cash flow to net income ~1.07), that mainly reflects losses converting into cash outflow rather than strong cash earnings.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2022	Mar 2021
Income Statement
Total Revenue	458.59K	0.00	0.00	0.00	0.00
Gross Profit	106.44K	-37.57K	-68.26K	-64.22K	0.00
EBITDA	-3.84M	-5.93M	-2.18M	-1.28M	-237.32K
Net Income	-4.05M	-6.06M	-2.26M	-1.36M	-237.32K
Balance Sheet
Total Assets	1.78M	2.91M	517.08K	320.47K	288.40K
Cash, Cash Equivalents and Short-Term Investments	344.38K	1.25M	398.88K	51.32K	281.84K
Total Debt	47.97K	68.68K	74.86K	94.79K	200.00K
Total Liabilities	2.64M	2.24M	2.38M	1.22M	425.13K
Stockholders Equity	-857.08K	664.52K	-1.86M	-900.79K	-136.73K
Cash Flow
Free Cash Flow	-4.72M	-7.66M	-559.92K	-818.36K	17.25K
Operating Cash Flow	-4.39M	-7.40M	-559.92K	-755.59K	17.25K
Investing Cash Flow	-328.69K	-257.76K	0.00	-62.77K	0.00
Financing Cash Flow	4.70M	8.51M	907.48K	15.25K	264.59K

UniDoc Health Corp Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.14
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:UDOC, the sentiment is Neutral. The current price of 0.14 is above the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.15, and below the 200-day MA of 0.20, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 49.91 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:UDOC.

UniDoc Health Corp Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VHI	68 Neutral	C$521.66M	-185.55	1.45%	―	59.34%	-23.48%
CHS	53 Neutral	C$11.85M	-11.57	―	―	16.04%	-455.38%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AIDR	48 Neutral	$52.68M	-2.31	-207.53%	―	―	7.04%
NARA	42 Neutral	C$4.49M	-4.68	―	―	―	81.01%
UDOC	41 Neutral	C$11.66M	-3.92	―	―	―	48.94%

UniDoc Health Corp Corporate Events

UniDoc Expands eHealth Footprint with H3 Health Cube Installation in Italy

UniDoc Health Corp. has successfully installed its H3 Health Cube in the Guardia Perticara Territorial eHealth Centre in Basilicata, Italy, in collaboration with its regional partner UniCheck SRL. The installation is part of a government-led eHealth initiative geared toward improving accessibility to healthcare services in underserved regions. The adaptable Health Cube was integrated into a historic site and is designed to offer primary care, specialized consultations, and diagnostic support, enhancing healthcare delivery for local communities and reinforcing UniDoc’s position as a key player in eHealth technologies.